Abstract: The present invention discloses novel compounds of Formula I: ( I ) possessing 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, cognitive disorders, and other conditions associated with 11β-HSD type 1 activity.
PLEASE SEE THE SPECIFICATION ATTACHED.
| # | Name | Date |
|---|---|---|
| 1 | 2277-mumnp-2008-wo international publication report(23-10-2008).pdf | 2008-10-23 |
| 2 | 2277-mumnp-2008-form 5(23-10-2008).pdf | 2008-10-23 |
| 3 | 2277-mumnp-2008-form 3(23-10-2008).pdf | 2008-10-23 |
| 4 | 2277-mumnp-2008-form 2(title page)-(23-10-2008).pdf | 2008-10-23 |
| 5 | 2277-mumnp-2008-form 2(23-10-2008).pdf | 2008-10-23 |
| 6 | 2277-mumnp-2008-form 1(23-10-2008).pdf | 2008-10-23 |
| 7 | 2277-mumnp-2008-description(complete)-(23-10-2008).pdf | 2008-10-23 |
| 8 | 2277-mumnp-2008-claims(23-10-2008).pdf | 2008-10-23 |
| 9 | 2277-mumnp-2008-abstract(23-10-2008).pdf | 2008-10-23 |
| 10 | 2277-MUMNP-2008-CORRESPONDENCE(24-12-2008).pdf | 2008-12-24 |
| 11 | 2277-MUMNP-2008-ASSIGNMENT(24-12-2008).pdf | 2008-12-24 |
| 12 | Form 27 [29-03-2016(online)].pdf | 2016-03-29 |
| 13 | Petition Under Rule 137 [11-04-2017(online)].pdf | 2017-04-11 |
| 14 | Form 27 [11-04-2017(online)].pdf | 2017-04-11 |
| 15 | ipindiaonline.gov.in_epatentfiling_online_frmPreview.asp.pdf | 2018-08-09 |
| 16 | Form-5.pdf | 2018-08-09 |
| 17 | Form-3.pdf | 2018-08-09 |
| 18 | Form-1.pdf | 2018-08-09 |
| 19 | abstract1.jpg | 2018-08-09 |
| 20 | 2277-MUMNP-2008_EXAMREPORT.pdf | 2018-08-09 |
| 21 | 2277-MUMNP-2008-US DOCUMENT(15-5-2012).pdf | 2018-08-09 |
| 22 | 2277-MUMNP-2008-REPLY TO EXAMINATION REPORT(15-5-2012).pdf | 2018-08-09 |
| 23 | 2277-MUMNP-2008-PETITION UNDER RULE-137(17-1-2013).pdf | 2018-08-09 |
| 24 | 2277-MUMNP-2008-PETITION UNDER RULE 137(15-5-2012).pdf | 2018-08-09 |
| 25 | 2277-MUMNP-2008-PCT CLAIMS(15-5-2012).pdf | 2018-08-09 |
| 26 | 2277-mumnp-2008-marked copy(4-11-2008).pdf | 2018-08-09 |
| 27 | 2277-MUMNP-2008-FORM2(GRANTED).pdf | 2018-08-09 |
| 28 | 2277-MUMNP-2008-FORM 3(15-5-2012).pdf | 2018-08-09 |
| 29 | 2277-MUMNP-2008-FORM 3(13-4-2009).pdf | 2018-08-09 |
| 30 | 2277-MUMNP-2008-FORM 26(15-5-2012).pdf | 2018-08-09 |
| 31 | 2277-MUMNP-2008-FORM 26(14-9-2011).pdf | 2018-08-09 |
| 32 | 2277-MUMNP-2008-FORM 2(TITLE PAGE)-(GRANTED).pdf | 2018-08-09 |
| 33 | 2277-mumnp-2008-form 18(4-11-2008).pdf | 2018-08-09 |
| 34 | 2277-mumnp-2008-form 13(4-11-2008).pdf | 2018-08-09 |
| 35 | 2277-MUMNP-2008-FORM 13(26-7-2012).pdf | 2018-08-09 |
| 36 | 2277-MUMNP-2008-FORM 1(30-8-2012).pdf | 2018-08-09 |
| 37 | 2277-MUMNP-2008-EP DOCUMENT(15-5-2012).pdf | 2018-08-09 |
| 38 | 2277-MUMNP-2008-DESCRIPTION(GRANTED).pdf | 2018-08-09 |
| 39 | 2277-MUMNP-2008-CORRESPONDENCE(IPO).pdf | 2018-08-09 |
| 40 | 2277-MUMNP-2008-CORRESPONDENCE(30-8-2012).pdf | 2018-08-09 |
| 41 | 2277-MUMNP-2008-CORRESPONDENCE(26-7-2012).pdf | 2018-08-09 |
| 42 | 2277-MUMNP-2008-CORRESPONDENCE(17-1-2013).pdf | 2018-08-09 |
| 43 | 2277-MUMNP-2008-CORRESPONDENCE(14-9-2011).pdf | 2018-08-09 |
| 44 | 2277-MUMNP-2008-CORRESPONDENCE(13-4-2009).pdf | 2018-08-09 |
| 45 | 2277-MUMNP-2008-CLAIMS(MARKED COPY)-(15-5-2012).pdf | 2018-08-09 |
| 46 | 2277-MUMNP-2008-CLAIMS(GRANTED).pdf | 2018-08-09 |
| 47 | 2277-mumnp-2008-claims(amended)-(4-11-2008).pdf | 2018-08-09 |
| 48 | 2277-MUMNP-2008-CLAIMS(AMENDED)-(15-5-2012).pdf | 2018-08-09 |